Patients with glaucoma who displayed an early treatment response to a 10 µg bimatoprost implant and experienced greater than 20% IOP lowering at 12 weeks had significantly greater odds of a long-term IOP response, according to a speaker.“Those patients that are greater than 20% reduction of their eye pressure actually ended up having a much greater likelihood of having a long-term